I am returning to work/school and need testing.

For your situation we recommend these options for testing:

DIAGNOSTIC
SARS-CoV-2 Diagnostic Respiratory PCR Test
Learn more
  • Diagnostic test for SARS-CoV-2, using real-time reverse transcriptase polymerase chain reaction (RT-PCR) technology
  • Detects the presence of SARS-CoV-2 viral RNA in respiratory samples • Determines current SARS-CoV-2 infection but does not indicate past i nfection or immunity
  • Utilizes Nasal or Nasopharyngeal swab
  • Additional collection services are required (cost is included in the price)
  • Rapid 24-48 hour turnaround time

Pros

  • Utilizes Nasal or Nasopharyngeal swab
  • Additional collection services are required (cost is included in the price)
  • Rapid 24-48 hour turnaround time Video Overview
DIAGNOSTIC
SARS-CoV-2 Diagnostic Salivary PCR Test
Learn more
  • Diagnostic test for SARS-CoV-2, using real-time reverse transcriptase polymerase chain reaction (RT-PCR) technology
  • Detects the presence of SARS-CoV-2 viral RNA in salivary samples
  • Determines current SARS-CoV-2 infection but does not indicate past infection or immunity
  • Utilizes simple at-home salivary collection
  • No additional collection services are required
  • Rapid 24-48 hour turnaround time
SURVEILLANCE
COVID-19 Immune Response Panel
Learn more

Serum test that measures both nucleocapsid (N-protein) and S-RBD antibodies

The COVID-19 Immune Response Panel measures both nucleocapsid (N-protein) and S-RBD antibodies. N-protein antibodies do not rise in response to COVID-19 S-RBD vaccinations. The combined serum IgM/IgG tests measure the body’s response to COVID-19 nucleocapsid (N) and spike protein receptor-binding domain (S-RBD) exposure. The N and S-RBD antibodies’ combination assay has a > 99% positive and negative predictive value 15 days after COVID-19 exposure. This test does not differentiate between IgM and IgG; studies indicate that joint testing is as or more reliable than individual IgM and IgG testing in confirming COVID-19 exposure.

SURVEILLANCE
COVID-19 Vaccine Response Screen
Learn more

Serum test which measures only the antibody response to the S-RBD protein

The COVID-19 Vaccine Response Screen measures only the antibody response to the S-RBD protein. Once the baseline immune response has been established, this test can be used post-vaccination to evaluate immune status. The average time for seroconversion has been estimated at 2-3 weeks. However, the strongest antibody responses will likely be seen after the second vaccine dose 6-8 weeks after the first inoculation.